C-GUD

T:GUD - KNIGHT THERAPEUTICS INC. - http://www.gud-knight.com

20:31:14 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
GUD - T	21.4	5.70	·	5.85	0.1	5.79	-0.07	-1.2	109.9	605	524	5.90 5.94 5.75	5.95 4.35	16:00:00	Apr 09	15 min RT 2¢
TSX - T	21.4	5.70	·	5.85	0.1	5.79	-0.07	-1.2	75.6	420	312	5.90 5.94 5.76	5.95 4.35	16:00:00		15 min
NEO ATS - U						5.77	-0.09	-1.5	9.2	50	54	5.875 5.90 5.75		15:55:15		15 min
Alpha - A						5.80	-0.06	-1.0	5.7	31	32	5.90 5.92 5.75		15:59:59		15 min
Omega - O						5.77	-0.09	-1.5	1.1	6	8	5.80 5.80 5.77		15:55:15		15 min
Pure - P						5.78	-0.08	-1.4	0.4	2	5	5.84 5.84 5.78		15:55:15		15 min
Chi-X - X						5.77	-0.09	-1.5	3.3	17	29	5.88 5.94 5.77		15:55:15		15 min
CX2 - H						5.77	-0.09	-1.5	5.5	30	26	5.86 5.93 5.75		15:55:15		15 min
CXD - D						5.79	-0.07	-1.2	1.5	8	12	5.87 5.89 5.79		14:34:18		15 min
TriAct - M						5.86			7.6	41	46			Sep 11-20		15 min

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
NOTE: Delayed ATS trade data is included - click System Status for more information

Hide ATS · Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · Company · Participants · 1yr Bulletins · Sedar · Historical · Options · Shorts · Portfolio

Recent Trades - Last 10 of 524

More trades...

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
16:00:00	T	5.79	-0.07	100	1 Anonymous	1 Anonymous	KQ
16:00:00	T	5.79	-0.07	100	1 Anonymous	39 Merrill Lynch	KQ
16:00:00	T	5.79	-0.07	600	1 Anonymous	1 Anonymous	KQ
16:00:00	T	5.79	-0.07	100	1 Anonymous	1 Anonymous	KQ
16:00:00	T	5.79	-0.07	63	1 Anonymous	7 TD Sec	Q
16:00:00	T	5.79	-0.07	83	7 TD Sec	65 Goldman	Q
16:00:00	T	5.79	-0.07	4	7 TD Sec	1 Anonymous	Q
16:00:00	T	5.79	-0.07	30	7 TD Sec	2 RBC	Q
16:00:00	T	5.79	-0.07	700	1 Anonymous	1 Anonymous	KQ
15:59:59	A	5.80	-0.06	100	1 Anonymous	39 Merrill Lynch	K

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins

News ReleasesIn The NewsOther

Date ET	Symbol	Price	Type	Headline
2024-03-27 08:10	C:GUD	5.44	SEDAR Annual Report803	SEDAR Annual Report
2024-03-22 07:58	C:GUD	5.27	In the News525	Globe says Knight seen "as a good long-term investment"
2024-03-21 13:42	C:GUD	5.23	SEDAR MD & A815	SEDAR MD & A
2024-03-21 10:45	C:GUD	5.39	News Release200	Knight Therapeutics loses $16.83-million in 2023
2024-03-21 07:50	C:GUD	5.39	SEDAR Annual Information Form802	SEDAR Annual Information Form
2024-03-21 07:50	C:GUD	5.39	SEDAR MD & A815	SEDAR MD & A
2024-03-21 07:45	C:GUD	5.39	SEDAR Audited Annual Financial Statements804	SEDAR Audited Annual Financial Statements
2024-03-14 08:26	C:GUD	5.28	News Release200	Knight Therapeutics to release 2023 results March 21
2024-03-07 07:52	C:GUD	5.51	In the News525	Globe says Knight Therapeutics kept at "outperform"
2024-02-29 12:43	C:GUD	5.55	News Release200	Knight Therapeutics rolls out Minjuvi in Brazil
2024-02-21 17:53	C:GUD	5.41	News Release200	Knight applies for fostamatinib marketing nod in Brazil
2024-02-06 11:27	C:GUD		News Release200	Knight Therapeutics rolls out Bijuva capsules in Canada
2024-01-25 10:34	C:GUD	5.51	News Release200	Knight Therapeutics licenses IPX203 from Amneal
2024-01-04 10:31	C:GUD	5.36	News Release200	Knight Therapeutics rolls out IMVEXXY in Canada
2023-12-19 10:49	C:GUD	5.15	News Release200	Knight Therapeutics licenses Qelbree from Supernus
2023-11-09 13:48	C:GUD	4.78	News Release200	Knight Therapeutics earns $9.58-million in Q3
2023-11-09 10:05	C:GUD	4.78	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2023-11-09 10:05	C:GUD	4.78	SEDAR Interim MD & A813	SEDAR Interim MD & A
2023-11-02 13:39	C:GUD	4.61	News Release200	Knight Therapeutics to release Q3 2023 results Nov. 9
2023-10-16 10:29	C:GUD	4.65	News Release200	Knight to roll out Minjuvi in Brazil in Q2 2024